Severity of chronic kidney disease and outcomes after admission to the intensive care unit
El Wadia H, Beauregard N, Silver SA, Wald R, Akbari A, Fremont D, Ramsay T, Knoll GA, Clark EG, Hundemer GL. JAMA Netw Open. 2026; 9(6): e2620192.
The Transparent Drug System for Patients Act, which was proclaimed in Ontario in 2006, mandated the establishment of a citizens’ council to help guide drug policy in Ontario. This report describes the theoretical and practical issues related to establishing a citizens’ council, presents approaches used in other jurisdictions, and recommends preferred options for the citizens’ council proposed in the Act.
Jeyanathan T, Dhalla I, Culyer T, Levinson W, Laupacis A, Martin DK, Sullivan T, Evans BK. November 2006
The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.